Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

NeuroMET mini symposium December 2017

15 Nov 2017

The second NeuroMET mini symposium was held at Charité - Universitätsmedizin Berlin, Berlin, Germany, on December 13, 2017. It was attended by Consortium members and stakeholders from clinical laboratories, industry and academia.

Following a brief introduction to NeuroMET, the symposium included sessions on MRI, cognition and biomarkers, and prompted much discussion between the participants.

Find more details of the presentations below.


Session: MRI

Structural analysis of 7T MR images in the NeuroMet study
- Laura Göschel, Clinic for Neurology, Charité - Universitätsmedizin Berlin, Berlin

The Promise of MRI and MRS at Ultrahigh Field for Alzheimer’s Disease
- Itamar Ronen, CJ Gorter Center for High Field MRI Research, Leiden University Medical Center, Leiden

Session: Cognition

Metrology of categorical data in psychometrics
- Prof. Leslie Pendrill, RI:SE, Göteburg

Session: Biomarkers

Methodological limitations of protein quantification in the cerebrospinal fluid for early diagnosis of Alzheimer´s dementia
- Prof. Oliver Peters, Clinic for Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin

microRNA as Alzheimer's Disease biomarkers
- Carla Divieto, INRIM, Turin

Amyloid-beta(1-42) seeding activity as a biomarker in Alzheimer's Disease
- Christopher Secker & Lisa Diez, Neuroproteomics, Max-Delbrück-Center for Molecular Medicine, Berlin-Buch 


For further information

Theresa Köbe
Charité - Universitätsmedizin Berlin

Ariane Fillmer
Physikalisch-Technische Bundesanstalt